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Background: Substantial opportunity exists to improve medication management in the period 
following a hospital discharge. The objective of this study was to assess and improve medication 
management during care transitions through pharmacist home visits and the use of an electronic 
personal health record (ePHR) system.
Methods: Recently discharged patients aged 50 years or older and having a chronic medical 
condition were offered the opportunity to meet with a pharmacist in the home setting to review 
medication instructions and receive a demonstration of an ePHR system. Patients agreeable 
to using the ePHR system were offered pharmacist support with setting up the ePHR system, 
having emphasis on documenting and reviewing medication regimens. Medication-related 
problems identified by the pharmacist during the visit were categorized according to ePHR use 
and by other characteristics.
Results: Thirty recently discharged patients with chronic disease were visited by a  pharmacist 
over a 6-month period. The percentage of medication-related problems identified by the 
 pharmacist was greater among those patients who agreed to use the ePHR system, as compared 
with patients whose visit did not include use of the ePHR (75% versus 40%, respectively; 
P=0.06). Differing types of medication-related problems were identified, including therapy 
duplications, lack of use of clinically important therapies, and patient nonadherence.
Conclusion: For some patients, the home setting can be a suitable venue for medication review 
and education after discharge from hospital. Assisting patients with setting up the ePHR system 
may enhance pharmacists’ ability to identify and resolve medication-related problems that may 
lead to rehospitalization.
Keywords: medication reconciliation, care transition, electronic personal health record
Introduction
Patients who are recently discharged from hospital have an increased risk of 
 experiencing an adverse drug event, and more than half of such adverse drug events may 
be preventable or ameliorable.1 In one study of the quality of medication instructions 
following a hospitalization, Coleman et al reported that 14% of recently discharged 
patients experienced a medication discrepancy, with an approximately equal proportion 
of discrepancies resulting from patient-related or health system-associated factors.2 
In another study of medication discrepancies at discharge, Wong et al reported that 
over 40% of patients experienced at least one unintentional medication discrepancy. 
In this study, incompletely written prescriptions and omissions of medications were 





identified as the most common types of errors.3 Yet even when 
medication reconciliation is performed accurately during the 
discharge process, patients may misunderstand medication 
instructions, particularly when changes occur in complex 
medication regimens. For example, in one review of medica-
tion reconciliation at discharge, Ziaeian et al detected either 
a medication error or a lack of patient understanding about a 
medication change in approximately 80% of patients.4
Payers, providers, and policy-makers have directed 
increased attention and resources towards improving medica-
tion safety during care transitions. Current strategies include 
implementing robust medication reconciliation processes, 
and promoting other elements of good transitional care, such 
as enhancing teamwork and communication, and utilizing 
health information technologies. In 2012, the American 
Pharmacists Association and the American Society of 
Health-System Pharmacists jointly issued a white paper 
entitled “Improving Care Transitions: Optimizing  Medication 
Reconciliation”.5 In this paper, these organizations describe 
an expansive vision for medication reconciliation, one that is 
“composed of multiple processes that together reduce medi-
cation errors, support safe medication use by patients, and 
encourage community-based providers and those practicing 
in hospitals and health systems to collaborate in organized 
medication reconciliation programs to promote overall con-
tinuity of patient care”.
Health information technologies can improve medication 
reconciliation functions.6,7 Patients can be empowered to 
assume management of their medication regimen through 
the use of an electronic personal health record system 
(ePHR). Using the ePHR, patients or authorized caregivers 
can maintain their medical information and medication list 
using a secure electronic application. Patients, pharmacists, 
and other care providers can utilize ePHR technology to 
promote greater patient self-efficacy in self-management of 
the medication regimen, and also to exchange and reconcile 
information among various information repositories.8 While 
these benefits are particularly apt during care transitions, 
research assessing the utility of ePHR systems to improve 
medication management is scant.9
Researchers from the University of Rhode Island College 
of Pharmacy piloted an intervention to improve medication 
management during care transitions. The project was one 
of several initiatives included in the Tech4Impact Program 
(Technologies for Improving Post-Acute Care Transitions), 
sponsored by the Center for Technology and Aging, 
a national leader in the use of patient-centered technologies 
for older adults.
Our intervention involved deploying pharmacists to visit 
the homes of recently discharged patients to review medica-
tion instructions and to offer patients free use of an ePHR 
system, with ongoing support in setting up and using the 
ePHR. We hypothesized that the pharmacist’s ability to iden-
tify medication-related problems would be greater among 
patients who used the ePHR system. To our knowledge, no 
study to date has coupled in-home pharmacist education 
with the use of an ePHR system to promote safe and effec-
tive medication management during care transitions. This 
report presents our findings in delivering this intervention 
during a 6-month period occurring between August 2011 
and February 2012.
Materials and methods
This was a prospective nonrandomized pilot study in which 
recently hospitalized patients were offered the opportunity to 
meet with a pharmacist in their home within 14 days of their 
discharge from hospital to review medication instructions 
and to receive a demonstration of an ePHR system. Patients 
were informed that the pharmacist home visit would include 
a medication regimen review and help in setting up the 
ePHR system, if desired. Usual care consisted of medication 
 reconciliation at discharge provided by hospital clinicians, but 
without subsequent home visits provided by pharmacists.
The ePHR utilized in this project was the ER-Card® sys-
tem, developed by ER-Card LLC of West Warwick, Rhode 
Island. This product features online password-protected 
sharing of health record information via the Internet, or by 
USB drive provided by the consumer. The ER-Card system 
provides staff support for assisting with completing and 
updating the contents of the patient’s record. Medical con-
ditions and medication information is self-reported by the 
patient, with pharmacists verifying medication lists with the 
patient’s pharmacy.
The study enrolled patients 50 years of age or older and 
having any of the following chronic conditions: cardiovas-
cular disease and related conditions (eg, atrial fibrillation), 
respiratory illness (eg, chronic obstructive pulmonary 
disease/asthma), and/or diabetes mellitus. As our focus was 
on medication self-management among community-dwelling 
patients, we did not recruit patients with dementia or patients 
who were transitioning from the hospital to a long-term care 
facility. The pharmacist home visit was offered to patients 
who were participating in an associated care transitions 
initiative conducted by the Rhode Island Quality Improve-
ment Organization (Healthcentric Advisors) in cooperation 
with Rhode Island’s Aging and Disability Resource Center. 
Drug, Healthcare and Patient Safety 2014:6
Table 1 characteristics of patients with chronic disease com­
pleting a pharmacist home visit following a hospitalization (n=30)
n %
recruitment source
 in­hospital recruitment 20 66.7
 Medicare QiO referral 7 23.3
 Medicaid rn referral 3 10.0
Patient age (years)
 50–64 7 23.3
 65+ 23 76.7
Sex
 Female 14 46.7
 Male 16 53.3
Primary diagnosis
 cardiovascular 24 80.0
 respiratory 3 10.0
 Diabetes 3 10.0
Abbreviations: QiO, quality improvement organization; rn, registered nurse.




Pharmacist visit and ePHr post discharge
Patients were also recruited via referral from Rhode Island 
Medicaid nurse case managers. A third pathway for patient 
recruitment was on-site solicitation of patients at Kent 
Hospital in Warwick, Rhode Island, which served as the 
predominant patient recruitment source.
Patients agreeable to the pharmacist home visit completed 
an informed consent process explaining the activities that 
the pharmacist would be providing during the home visit. 
Patients were informed that that they were not required to 
utilize the ePHR system to receive the pharmacist home visit, 
and that if they decided to utilize the ePHR system, their 
information could be shared with other health care providers 
only if they provided permission. Those patients deciding to 
utilize the ePHR system completed an authorization form 
routinely required by the ePHR vendor for compliance with 
the Health Insurance Portability and Accountability Act. The 
ePHR was offered to patients at no cost, and patients were 
allowed to discontinue their use of the ePHR at any time. 
The study was approved by the Institutional Review Board 
on Human Subjects at the University of Rhode Island and 
Kent Hospital.
For patients consenting to participate in the study, a home 
visit was scheduled by the study pharmacist for a suggested 
period of 2 hours. When a medication-related problem was 
identified during the medication review, the pharmacist 
discussed the concern with the patient, and encouraged 
the patient to contact the prescriber or pharmacy when 
appropriate. The pharmacist demonstrated the ePHR program 
using a laptop computer, and if the patient was agreeable to 
trying the ePHR system, the pharmacist supported the patient 
in entering their medical information and medication list 
into the ePHR system. During the home visit the pharmacist 
completed a data collection form that captured information 
describing the medication-related problems identified and 
other data relevant to the study.
We categorized study participants according to the refer-
ral source and by the primary diagnosis associated with the 
recent hospitalization. Age was categorized as 50–64 years 
or 65 years or older. We categorized the types of medication-
related problems identified during the home visit as involving 
therapy duplication, interactions, medication cost, or incor-
rect use or underuse of a medication (eg, poor adherence). 
We compared the frequency of medication-related problems 
identified between users and nonusers of the ePHR system, 
overall and according to patient age and sex. We also docu-
mented medication discrepancies using the tool developed 
by Dr Eric A Coleman’s Care Transitions Program®,10 which 
categorizes events as patient-related or health-system related. 
Our results are presented here as descriptive statistics, with 
the chi-square test used to determine the statistical signifi-
cance of differences in observed rates of medication-related 
problems between users and nonusers of the ePHR. Fisher’s 
exact test was used where any cell size was less than five 
observations.
We attempted to contact patients no earlier than 30 days 
following the home visit to enquire about their satisfaction 
with the pharmacist visit, to determine if patients continued 
to utilize the ePHR system, and to ascertain if patients had 
been rehospitalized in the period following the home visit.
Results
Approximately 300 patients were identified as eligible for 
our program and were approached by study recruiters. While 
59 of these eligible patients initially agreed to participate 
in the study, we were unable to schedule a home visit with 
29 patients, because some did not return our subsequent tele-
phone calls to schedule the home visit, while other patients 
changed their mind about participating, transitioned to a 
long-term care setting or died. The study pharmacists com-
pleted home visits for a total of 30 patients, with 20 of these 
patients agreeing to utilize the ePHR system. Among the 
30 patients visited, 16 (53%) were male and 23 (77%) were 
65 years of age or older. The majority of patients had been 
hospitalized due to a cardiovascular-related illness (n=24), 
while six patients were hospitalized for an exacerbation of 
their respiratory illness or diabetes (see Table 1).
At each patient home visit, the pharmacist performed a 
medication regimen review and documented medication-
related problems that were identified. Table 2 presents 
the range of problems discovered, which are categorized 





as cost-related, involving therapeutic duplication, drug 
interaction, underuse (lack of use) of a clinically important 
therapy, or having incorrect or unclear instructions for 
medication use. Several patients discontinued a clinically 
important medication due to cost, while other patients did 
not appear to be utilizing indicated therapies (eg, lack of 
aspirin use following a myocardial infarction, with no 
apparent contraindication to aspirin therapy). Instances 
of therapeutic duplication included concomitant use of 
two proton pump inhibitors, use of two different albuterol 
inhaler products, and use of multiple products containing 
acetaminophen.
The percentage of medication-related problems detected 
by the pharmacist was higher among those patients agreeing 
to use the ePHR system (15/20, 75%), as compared with 
patients who did not use the ePHR (4/10, 40%). Medication-
related problems were also identified more frequently among 
patients who were younger than 65 years of age, as compared 
with older patients (71% versus 61%, respectively), and 
were identified more frequently among males as compared 
with females (69% versus 57%, respectively). Medication-
related problems were identified among approximately 60% 
of patients who were recently hospitalized for a cardiovas-
cular-related condition, and among 67% of patients who 
were recently hospitalized for a respiratory illness. Despite 
large proportional differences across several of these cross-
tabulations, statistically significant differences were not 
observed, reflecting the small sample size in this pilot study 
(Table 3).
Table 4 presents the frequencies and types of medication 
discrepancies identified during the home visit using the Care 
Transitions Program® Medication Discrepancies Tool for 
Multiple Events.10 Discrepancies were detected among 16 of 
the 30 patients we visited (53%): six of the discrepancies were 
categorized as relating to patient-associated factors, while ten of 
the discrepancies were considered to have resulted from system-
related factors. The most frequently observed discrepancy was 
“conflicting information from different informational sources”, as 
documented in five of the 30 home visits that were completed.
We succeeded in following up with 19 of the 30 patients 
whom we visited. Of these 19 patients, three had been 
Table 2 Examples of medication-related problems identified 
during pharmacist home visits following hospital discharge
Cost-related Medication underuse
•  Patient discontinued  
antiplatelet medication  
due to cost
•  Patient discontinued  
cholesterol medication  
due to cost
•  Patient discontinued  
anticoagulant medication  
due to cost
•  Diabetes and post­myocardial  
infarction: no aspirin, acei/arB, 
or statin prescribed  
(not contraindicated)
•  Patient did not continue aspirin  
therapy as instructed (intentional 
nonadherence)
•  Diabetes, no acei/arB 
prescribed (not contraindicated)
Therapy duplication Incorrect medication use
•  Patient taking multiple 
acetaminophen­ 
containing products
•  Patient taking both  
omeprazole and  
esomeprazole
•  Duplication of albuterol  
(use of two different  
brand name inhalers)
•  Patient taking albuterol inhaler 
three puffs once daily instead of  
one puff three times a day as 
ordered
•  Patient using sublingual 
nitroglycerin incorrectly
Drug interactions Unclear instructions
•  Patient taking thyroid  
medication at same time  
as calcium supplement
•  Patient uncertain if supposed 
to continue or stop antiplatelet 
medication
•  Patient unaware of  
drug­food (alcohol)  
interactions
•  Use of both enoxaparin  
and warfarin with no plan  
to stop either drug
•  Different dose of medication 
taken at home versus what is  
documented on discharge 
instructions
Abbreviations: acei, angiotensin­converting enzyme inhibitor; arB, angiotensin­
receptor blocker.
Table 3 Frequency of medication-related problems identified 
during home visit following discharge: results stratified by ePHR 
use, recruitment source, and other patient characteristics










n % n %
ePHr use
 Yes (20) 15 75.0 5 25.0
 no (10) 4 40.0 6 60.0 0.061
recruitment source
 in hospital (20) 12 60.0 8 40.0
  QiO/aDrc  
referral (7)
5 71.4 2 28.6
  Medicaid referral (3) 2 66.7 1 33.3 0.851
Patient age
 50–64 years (7) 5 71.4 2 28.6
 65+ years (23) 14 60.9 9 39.1 0.901
Sex
 Female (14) 8 57.1 6 42.9
 Male (16) 11 68.8 5 31.2 0.707
Primary diagnosis
 cardiovascular (24) 14 58.3 10 41.7
 respiratory (3) 2 66.7 1 33.3
 Diabetes (3) 3 100 0 0 0.542
Note: *chi­square/Fisher’s exact test.
Abbreviations: QiO, quality improvement organization; aDrc, aging and 
Disability resource center; ePHr, electronic personal health record.




Pharmacist visit and ePHr post discharge
rehospitalized within 30 days (3/19, 16%). Patients who 
were surveyed at follow-up expressed a high level of sat-
isfaction with the pharmacist home visit, with all patients 
responding affirmatively to our follow-up survey question: 
“Do you think that the pharmacist home visit was helpful in 
reviewing your medications and addressing your questions?” 
Seven patients reported that they had used the ePHR to share 
information with care providers during their post-discharge 
medical visits.
Discussion
In this pilot program, pharmacists conducting home visits 
frequently identified medication-related problems among 
recently discharged patients. At least three of the 30 patients 
had discontinued an important medication therapy due to high 
cost. In these instances, the pharmacist instructed the patient 
to contact her/his health care provider to discuss treatment 
options, which might include switching to an affordable 
alternative therapy (eg, changing to a generic cholesterol-
lowering medication). Additionally, several patients reported 
errors related to their medication regimen that occurred 
during their transitioning into or out of hospital, with 16 
such discrepancy events documented using the Medication 
Discrepancy Tool®.
Among the 30 patients who were visited by the phar-
macist, 20 agreed to use the ePHR technology, and seven 
patients reported that they had used the ePHR to share 
information with their care providers during follow-up visits 
or rehospitalizations. While these results indicate that the 
ePHR system can be effectively used by patients during care 
transitions, our sample size was too small to draw any firm 
conclusions regarding the characteristics of patents who are 
more likely to effectively utilize an ePHR to manage their 
medication regimen.
This intervention was challenging to operationalize. 
Foremost, patient recruitment was difficult, because many 
of the patients whom we encountered were not agreeable 
to meeting with the pharmacist in their home. Patient per-
ceptions regarding the role of the pharmacist in the health 
system may have posed a barrier to our work, as pharmacists 
do not commonly enter the patient’s home to provide medi-
cation counseling services. The lack of awareness among 
patients of the potential benefits of an ePHR system also 
posed a barrier to recruitment. We provided an explana-
tion of the ePHR system and its potential benefits during 
recruitment, and as an element of the informed consent 
process. However, it was challenging to effectively explain 
the potential utility of the ePHR during our brief recruitment 
encounters, especially considering that our population of 
focus included hospitalized or recently hospitalized patients 
who were often severely ill. Additionally, approximately 
half of the patients who consented to participate in the 
study subsequently changed their mind about completing 
the home visit, or did not return telephone calls when the 
scheduler contacted them.
Our study had several limitations that should be consid-
ered in interpreting our findings. Most importantly, it should 
be recognized that this was a pilot study involving a small 
number of patients. Larger scale application of the model is 
warranted before any strong conclusions can be made about 
the benefits of ePHR systems to aid medication management 
during care transitions. The small sample size also limited 
our ability to determine a difference in effectiveness of the 
intervention according to the characteristics of the patients 
studied. Additionally, the nonrandomized design may have 
resulted in selection bias, whereby participating patients may 
have generally been more accepting of the role of pharmacists 
and of information technology. Another limitation of our 
study pertains to the role of the pharmacist in our model, 
which did not include direct intervention with the patient’s 
pharmacy or prescribers to pursue each medication-related 
problem identified to its resolution. We believe that establish-
ing more formalized communications with health care team 
members would be an important step towards ensuring that 
the visiting pharmacist’s observations and recommendations 
are best incorporated into clinical decision-making. Finally, 
Table 4 Medication discrepancies identified during pharmacist 
home visits following a hospital discharge (n=30)*
Patient-associated factors System-associated factors
•  adverse drug reaction or  
side effects (n=0)
•  intolerance (n=0)
•  Did not fill/need  
prescription (n=0)
•  Money/financial  
barriers (n=3)
•  intentional  
nonadherence (n=2)
•  nonintentional  
nonadherence (n=1)
•  Performance deficit (n=0) 
Total 6/30 (20%)
•  Prescription with known allergy/
intolerance (n=0)
•  Conflicting information from different 
informational sources (n=5)
•  confusion between brand versus 
generic name (n=0)
•  Discharge instructions incomplete, 
inaccurate, or illegible (n=1)
•  Duplication (n=3)
•  incorrect dosage (n=0)
•  incorrect quantity (n=0)
•  incorrect label (n=0)
•  cognitive impairment not 
recognized (n=0)
•  need for assistance not  
recognized (n=1) 
Total 10/30 (33.3%)
Notes: *Sixteen discrepancies in total identified among 30 patients visited (53.3%). 
Identified using the Medication Discrepancy Tool for multiple events, Care 
Transitions Program® (http://www.caretransitions.org/).
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we were unable to follow up with 11 of the 30 patients to 
determine their satisfaction with the intervention, or if they 
continued to use the ePHR system.
Conclusion
Our findings from this pilot study suggest that pharmacist 
home visits following a hospitalization can aid in identify-
ing medication-related problems. The frequency and clinical 
significance of the problems identified suggests a need for 
increased involvement of pharmacists during care transitions. 
The ability to identify such problems may be enhanced when 
pharmacists work together with patients to review and enter 
the discharge medication list into an ePHR system.
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